UC a three-time winner of OFC awards

Orthopaedic researcher Chia-Ying “James” Lin wins award for technology that can aid in human tissue growth, repair and prevention

University of Cincinnati researcher and educator Chia-Ying “James” Lin was honored Friday, Oct. 11, as the runner-up for the 2019 Ohio Faculty Council (OFC) Technology Commercialization Award.

Lin,  director of the Orthopaedic Research Laboratories in the UC Department of Orthopaedic Surgery and the Mary S. and Joseph S. Stern Jr. Endowed Chair in Musculoskeletal Research, was recognized for his work in developing Amplicore, a biopharmaceutical company specializing in a unique approach for aiding soft skeletal tissue repair. The licensed technology developed by Lin’s company involves a novel pharmaceutical delivery method that has been shown to promote cartilage repair, retard skeletal degenerative diseases and reduce pain and inflammation.

The award went to Ohio State University’s Katrina Cornish for her accomplishments in developing and licensing technology that can extract material from the guayule shrub, which can yield sustainable natural rubber latex products. 

Lin says he is honored to be this year's runner-up.

Professor Chia-Ying Lin heashot

“Receiving the honor is a great encouragement from the state government to recognize our endeavors,” says Lin. “The award also shows the leadership is determined to foster biotechnologies in the state of Ohio and make the place as an emerging cluster for investors who normally only seek opportunities at coastal bio-hubs.”

Lin’s recognition is a reflection of the emphasis UC places on academic excellence and innovation in its strategic direction, Next Lives Here

“Faculty in the state of Ohio make a profound impact on students and on the health of our economy, and the OFC celebrates the role our excellent faculty play in economic development,” notes Marc Scott, acting OFC chair. “Dr. Cornish’s and Dr. Lin’s work are stellar examples of the impact faculty make across Ohio. Without Ohio’s investment in higher education and commitment to academic freedom, we would have far fewer such examples to celebrate.”

The Ohio Faculty Council, which represents faculty at all four-year public universities in Ohio, launched its annual Technology Commercialization Award in 2016 to recognize a faculty member in the state university system for exceptional research, discoveries and the translation of those discoveries into marketable products and services. Ohio Department of Higher Education Vice Chancellor Mike Duffey presented the awards.

“We expect that Amplicore will be the first of a series of startups that develop from his unique blend of engineering and medical research,” says Lin’s nominator Geoffrey Pinski, the director of Tech Transfer at UC’s Office of Innovation.

This is the second innovation recognition that Lin has received in 2019. MTF Biologics, the world’s largest tissue bank, named Lin this year’s recipient of the J.R. Neff Award. Named in honor of the late orthopaedic surgeon and researcher, James R. Neff, this award goes to an individual whose work in the orthopaedics field “embodies dedication, perseverance and intense curiosity.”

“While treatments for degenerative joint diseases and soft tissue injury still present unmet needs and perhaps the greatest challenges to the orthopaedic medical practice, our new invention to develop novel injectable therapeutics sheds a hope to provide promising alternatives to treat these disorders,” says Lin. 

Last year the Ohio Faculty Council recognized Jay Lee, a professor in UC’s College of Engineering and Applied Science, with the Technology Commercialization Award for Lee’s contribution to the field of industrial artificial intelligence. The year prior the recognition went to UC College of Engineering and Applied Science professor Jason Heikenfeld, for developing a suite of new sensor technology in his Novel Devices Lab.Replace with your text

Next Lives Here

Next Lives Here, the University of Cincinnati’s strategic direction, defines our moment and our momentum. More nimble and more robust than a plan, Next Lives Here announces our vision to the world—to lead urban public universities into a new era of innovation, impact, and inclusion.

Related Stories


Everyday Health: Does chest pain always mean a heart attack?

November 28, 2022

The American Heart Association (AHA) says that chest pain accounts for more than 6.5 million emergency room visits each year in the United States, plus nearly 4 million outpatient visits. While not all episodes of chest discomfort turn out to be life-threatening, chest pain is the most common symptom of a heart attack in adults of all ages, so it needs to be taken seriously. In a story posted by Everyday Health, Richard Becker, MD, of the UC College of Medicine is one of the experts quoted.

Debug Query for this